Recessive and domiAant inheritance of IGHD are associated wit stinct phenotypes. Type I is more common, autosomal recessive owth hormone (GH) responsive, and insulin sensitive with pica1 facies. Type I1 is autosomal dominant and insulin and resistant. Dominant father-child inheritance of a type I enotype has, however, been suggested in three families, all th very short fathers. Two pairs of brothers, first cousins, presented with IGHD in rly childhood. The mother of one pair (KG height 147 cm) and r brother (RT height 176 em), the father of the others, showed sent or grossly subnormal GH responses to L-Dopa and insulin poglycemia. Pituitary function was otherwise normal. Neither rriage was consanguinous and the spouses of KG and RT were related. All 4 cousins respbnded remarkably well to GH #as observed in all ethnic groups. The incidence of rare PI types appeared to increase in the births following the first one and to decrease in those of higher order.
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A t b p t s at redmtian of intraQlLular cystine in infantile cystinosis, has been reported previomly in 3 patients using dithiothreitml (2 patients) or cysteamim (nercaptoethylandne) (1 patient). We evaluated the benefit of a dinaticm of asmrbic acid and cystearnire in a ll-u~nth~ld boy with FanaxLi's syndnrre and cystinosis.
Ihe patient's granulccytes ormtained 5.2 -13 n u~1 of cystire/rq of protein (m& < 0.1 ml/ng pmtein) and qstine crystaLs e r e present in the bQE namw. Cn?atinire c l e a r m e (E-1 was 1 3 ml/nrin/1.73 m2 pre-treatnent. h m r b i c acid was q v m as a calciun salt in a dose of 2 ny/kg/day. #as observed in all ethnic groups. The incidence of rare PI types appeared to increase in the births following the first one and to decrease in those of higher order.
(Supported by NATO Grant 554).
USC Hed. Sch., Dept. Pediatrics, Los Angeles The Justification Hypothesis (J. Ped. 81:834, 1972) proposes that deficiencies in non-essential amino acids might cause mental retardation. The mother heterozygous for synthesis of any one of the non-essential amino acids would deprive her fetus partially and the heterozygous or homozygous fetus would be more or less unable to make up for the deficiency. Berman and Ford (Lancet i: 767, 1977) showed that such concatenation of heterozygous mother and heterozygous fetus is associated with significantly lower IQ. Our own wark has verified this finding. The possibility that heterozygosity for PKU in mother and fetus might be a cause of a 1arq.e amount of "non-specific" mental retardation was tested by looking for associated heterozygosity for PKU in mother and child among.12 families in a genetic clinic. Although there is no evidence of PKU in any of these families three showed such association. This is more than 10 times chance and suggests that a llajor factor in non-specific mental retardation is indeed heterozygosity in mother and fetus, depriving the developing fetus of a ?orma1 supply of tyrosine.
DRAMATIC CLINICAL RESPONSE TO COFACTOR THERAPY IN AD-
VANCED METHYLMALONIC ACIDEMIA (MMA) . 'Gre or A.
'Francis S. Wri ht and 2Robert j. ;esnick.
~n i i e s o t a
Hospitals, MinneaSchool of Medicine, Division of Medical F~~~-responsive MMA results from inherited defects in the synthesis of 5'-deoxyadenosyl -cobal amin(cbl), the cofactor required for Methylmalonyl-CoA-mutase (MMM) activity. Homozygotes with these enzyme defects manifest systemic acidosis, failure to thrive, mental retardation, severe hypotonia and death in childf MMA in a 3l/2 yr. old, acidotic, retardby the findings of massive amounts of urid ( m a ) and deficient MMM activity in culmatic cell hybridization studies with other er defect to be in the cbl a complementabiochemical and clinical responses were obin restriction(P-R) and B12 supplementation g/gCr. prior to treatment; P-R (1.5g/kg/ by day 8. BlzS (1 mg 1Mlday)c m a to 1.591 g/gCr. by day 14. A trial of 3 g protein/ cglday t m a 10 fold. Subsequently, B12S ( l h g p.o.lday) and P-R + and maintained m <l.Og/gCr. for the last 12 mos. Reversal of her growth, neurologic and intellectual deficits has been documented; bone age t from 11/2 to 3l/z yrs., r hypotonia, normalization of EEG, t motor skills and 1.4. + from 66 to 100. These findings support the efficacy of B12S and P-R therapy in untreated advanced MMA. hanges in the frequency of de novo interchange trisomies are ifficult to investigate directly because of the large population ase required. (In 50,000 consecutive newborns studied cytogeetical ly only one mutant case has been detected.) In contrast, he ratio of de novo interchange trisomy to 47, trisomy provides r e m available indirect index for the former event (Genetics 3: s33, 1976 ). This ratio is best considered by limiting analsis to younger mothers because the two cytogenetic outcomes difr markedly in their relative change in frequency with advancing ternal age. In data from New York State chromosome registry e ratio of de novo interchange trisomy 21, to 47,trisomy 21 in thers under 30 was about .04 prior to 1973 . In 1973 -1975 
